Furazabol
- Level
- Commodity
- Parent
- 51182000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51182029This classification denotes an anabolic steroid with the molecular formula C20H30N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2W07HSP5PX, chemically known as 17-methyl-5alpha-androstano(2,3-c)furazan-17beta-ol but generally known as furazabol, which bears US NIH Compound Identifier 14708. European Medicines Agency schedules Furazabol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07833MIG. The term FURAZABOL is an International Non-Proprietary Name. FURAZABOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule furazabol under HS 29349990 and SITC 51579. As of Q4 2014, FURAZABOL remains the US FDA Preferred Term for this commodity. Furazabol bears US NLM identifiers UMLS ID C0060855 and NCI Concept Code C65782. SMILES: OC1(C2(C(C3C(C4(C(CC3)CC3NONC3C4)C)CC2)CC1)C)C.
Same parent
Under 51182000 · 73Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.